Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-RELOAD - ARMYDA-RELOAD — Presented at SCAI-ACC i2 Summit/ACC 2008

Description:

The goal of this trial was to evaluate the safety and efficacy of an additional 600 mg clopidogrel dose prior to percutaneous coronary intervention (PCI) compared with placebo in patients undergoing revascularization.